Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2005
09/01/2005US20050191290 Cell with immunoglobulin-free light chain (Ig-LC) receptor capable of activating signal transduction pathway upon binding to receptor; mast cell is activated and stimulated to degranulate; skin disorders, asthma, psoriasis, inflammatory bowel disease, rheumatoid arthritis, lupus, Sjogren*s syndrome
09/01/2005US20050191278 Coronary artery disease treatment
09/01/2005CA2788707A1 Compositions and methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells
09/01/2005CA2596790A1 Engrafted plants resistant to viral diseases and methods of producing same
09/01/2005CA2559952A1 Instrument, method and kit for detecting lactobacillus brevis and lactobacillus lindneri
09/01/2005CA2558685A1 Nucleic acid construct containing fulllength genome of human hepatitis c virus, recombinant fulllength virus genome-replicating cells having the nucleic acid construct transferredthereinto and method of producing hepatitis c viral particle
09/01/2005CA2558682A1 Targeted delivery of rna interference molecules for the treatment of ige-mediated disorders
09/01/2005CA2557837A1 Fructoseamine 3 kinase and the formation of collagen and elastin
09/01/2005CA2557595A1 Vectors having both isoforms of beta-hexosaminidase and uses of the same
09/01/2005CA2557424A1 Methods for protein production
09/01/2005CA2557333A1 Antifungal peptides
09/01/2005CA2556997A1 Methods for genetic diversification in gene conversion active cells
09/01/2005CA2556913A1 Solid-fluid composition and uses thereof
09/01/2005CA2556861A1 Protein ligands for nkg2d and ul16 receptors and uses thereof
09/01/2005CA2556594A1 3'-end nucleoside unit comprising phosphoramidite
09/01/2005CA2556593A1 Silyl linker for solid-phase synthesis of nucleic acid
09/01/2005CA2556547A1 Low maintenance turfgrass
09/01/2005CA2556418A1 Methods and materials using signaling probes
09/01/2005CA2556336A1 Desaturase enzymes
09/01/2005CA2556229A1 System immune activation method using non cpg nucleic acids
09/01/2005CA2556190A1 Identification of soybeans having resistance to phytophthora sojae
09/01/2005CA2556186A1 Methods for coupling tomato yello leaf curl virus and root knot nematode resistance alleles in tomato
09/01/2005CA2556178A1 Methods and compositions for inferring eye color and hair color
09/01/2005CA2556177A1 Genetic predictability for acquiring a disease or condition
09/01/2005CA2556027A1 Monoclonal antibodies that specifically block biological activity of a tumor antigen
09/01/2005CA2555984A1 Combined immunotherapy of fusion cells and interleukin-12 for treatment of cancer
09/01/2005CA2555972A1 Hyphal growth in fungi
09/01/2005CA2555820A1 Cdr-repaired antibodies
09/01/2005CA2555737A1 Schizochytrium fatty acid synthase (fas) and products and methods related thereto
09/01/2005CA2555208A1 Nucleic acid molecules encoding novel murine low-voltage activated calcium channel proteins, designated-alpha 1h, encoded proteins and methods of use thereof
09/01/2005CA2498910A1 Animal immunocontraceptives expressed in plants and uses thereof
08/2005
08/31/2005EP1569156A2 Method of selecting optimized SNP marker sets from multiple SNP markers associated with a complex disease
08/31/2005EP1569155A1 Method of detecting an error spot in a DNA chip and system using the method
08/31/2005EP1568787A1 Nucleic acid sequences that can be used as primers and probes in the amplification and detection of all subtypes of HIV-1
08/31/2005EP1568785A2 Method for detecting oligonucleotides and determining base sequence of nucleic acids
08/31/2005EP1568779A1 HSV strains for the oncolytic treatment of cancer
08/31/2005EP1568778A1 Hydantoinase from agrobacterium
08/31/2005EP1568777A1 Deletion mutants from Neisseria glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
08/31/2005EP1568776A2 DNA coding for mutant isopropylmalate synthase, l-leucine-producing microorganism and method for producing l-leucine
08/31/2005EP1568775A1 Cancer-associated gene
08/31/2005EP1568774A2 Recombinant production of novel polyketides
08/31/2005EP1568772A2 Human growth hormone variants
08/31/2005EP1568771A2 Human growth hormone variants
08/31/2005EP1568769A1 ENA NUCLEIC ACID DRUGS MODIFYING SPLICING IN mRNA PRECURSOR
08/31/2005EP1568767A2 Dna fragments of lav genes
08/31/2005EP1568766A1 Device for pretreating specimen
08/31/2005EP1568765A1 Method for genetic diversification in gene conversion active cells
08/31/2005EP1568708A2 Methods and medical uses of nucleic acids encoding a TRAF inhibitor
08/31/2005EP1568705A1 Method and apparatus for concentration and purification of nucleic acid
08/31/2005EP1568704A1 Novel 2' ,5' -oligoadenylic acid analogues
08/31/2005EP1568383A2 Use of an oligonucleotide or its active derivative for the preparation of a pharmaceutical composition for inhibiting the formation of metastases in cancer treatment
08/31/2005EP1568376A2 Use of alpha-1 antichymotrypsin for the manufacture of a composition for treatment, prevention or diagnosis of poorly healing diabetic or arterial wounds
08/31/2005EP1568373A2 Inducing cellular immune responses to HER2/neu using peptide and nucleic acid compositions
08/31/2005EP1568273A1 METHOD OF CONSTRUCTING NONHUMAN MAMMAL HAVING RNAi PHENOTYPE
08/31/2005EP1567863A2 Methods of therapy and diagnosis
08/31/2005EP1567858A2 Fish disease models and uses thereof
08/31/2005EP1567675A2 Methods for using primers that encode one strand of a double-stranded promoter
08/31/2005EP1567672A2 Expression profiling based on histocultures
08/31/2005EP1567662A2 Caged sensors, regulators and compounds and uses thereof
08/31/2005EP1567658A2 Intron fusion construct and method of using for selecting high-expressing production cell lines
08/31/2005EP1567656A2 Method and apparatus for performing submicroliter reactions with nucleic acids or proteins
08/31/2005EP1567653A2 Recombinant poxvirus comprising at least two cowpox ati promoters
08/31/2005EP1567651A2 Production of pharmaceutically active proteins in sprouted seedlings
08/31/2005EP1567650A1 Plant stress tolerance genes, and uses therefor
08/31/2005EP1567649A1 Bioremediation with transgenic plants
08/31/2005EP1567648A1 Expression vector, methods for the production of heterologous gene products, and selection method for high-producing recombinant cells
08/31/2005EP1567647A1 Soluble notch-based substrates for gamma secretase and methods and compositions for using same
08/31/2005EP1567646A1 Phosphorylated ndr kinase
08/31/2005EP1567645A1 Inhibitors of gst a3-3 and gst a1-1 for the treatment of cancer
08/31/2005EP1567644A2 Tissue specific genes and gene clusters
08/31/2005EP1567643A1 Mixture of at least two fusion proteins, the production thereof and the use of the same
08/31/2005EP1567641A2 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer
08/31/2005EP1567640A2 Pokeweed antiviral protein polypeptides with antiviral activity
08/31/2005EP1567554A1 Icam-4 binding sites
08/31/2005EP1567550A2 Peptide conjugate useful for cell nucleus molecular imaging and tumor therapy
08/31/2005EP1567549A1 Methods for the production of methionine
08/31/2005EP1567548A1 Engineering redox proteins
08/31/2005EP1567547A2 Hepatisis c virus nonstructural protein 4a (ns4a) is an enhancer element
08/31/2005EP1567544A2 Use of hmgb polypeptides for increasing immune responses
08/31/2005EP1567541A2 Rationally designed antibodies
08/31/2005EP1567539A2 Allele-specific rna interference
08/31/2005EP1567538A2 Antisense modulation of gfat expression
08/31/2005EP1567537A2 Lna-cpg conjugates
08/31/2005EP1567198A2 Materials and methods for treating ocular-related disorders
08/31/2005EP1567196A2 Modulation of notch3 expression
08/31/2005EP1567190A2 A hepatitis c virus codon optimized non-structural ns3/4a fusion gene
08/31/2005EP1567189A1 Malaria vaccine
08/31/2005EP1567009A2 Antisense modulation of notch (drosophila) homolog 4 expression
08/31/2005EP1567007A2 Compositions and methods for cancer diagnosis and therapy
08/31/2005EP1567000A2 Bentgrass event asr-368 and compositions and methods for detection thereof
08/31/2005EP1566999A2 Production of increased oil and protein in plants by the disruption of the phenylpropanoid pathway
08/31/2005EP1558738A4 Methods for regulating plant gaba production
08/31/2005EP1485502A4 Internal positive control for probe-based nucleic acid molecule assays and methods of making and using therof
08/31/2005EP1484959A4 Nucleic acid constructs and methods for producing altered seed oil compositions
08/31/2005EP1470245A4 Single nucleotide polymorphisms diagnostic for schizophrenia
08/31/2005EP1463532A4 Dose response-based methods for identifying receptors having alterations in signaling
08/31/2005EP1451331A4 A promoter for transformation of monocot plants
08/31/2005EP1442137A4 Universal nucleotides for nucleic acid analysis
08/31/2005EP1417321A4 Double fructan beets
08/31/2005EP1395612B1 Modified recombinase
1 ... 1959 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 1970 1971 1972 1973 1974 1975 1976 1977 1978 1979 ... 4023